MMP2 and melanoma: We recently described the recognition, on about half HLA-A2 melanoma cell lines, of a new HLA-A2-restricted tumor antigen derived from Matrix Metalloproteinase 2 (MMP-2) by a CTL clone (M134.12) derived from Tumor Infiltrating Lymphocytes (TILs) of a melanoma patient [9].